美国侵袭性念珠菌病相关住院的流行病学,2002-2012年
该研究基于美国医疗成本与利用项目住院记录,分析2002-2012年33个州侵袭性念珠菌病相关住院(排除新生儿)。年龄调整年均住院率为5.3/10万,65岁以上成人风险最高,住院中位21天,22%住院期间死亡,中位住院费用46,684美元,2005-2012年年龄调整年率下降。
要点
- 65岁以上成人侵袭性念珠菌病住院风险最高,尤其是男性。
- 住院期间死亡率为22%,中位住院时间21天,中位住院费用46,684美元。
- 2005-2012年男性和女性年龄调整住院率均下降。
核心结论
- 侵袭性念珠菌病相关住院死亡率高,但2005-2012年发病率呈下降趋势。
研究设计与样本
- 基于美国医疗成本与利用项目住院记录,提取2002-2012年33个州数据,使用ICD-9-CM编码识别侵袭性念珠菌病,排除新生儿病例。
主要发现
- 总体年龄调整年均住院率为5.3/10万人口。
- 65岁以上成人风险最高,尤其是男性。
- 住院中位时间为21天,22%的患者住院期间死亡。
- 住院中位未调整相关费用为46,684美元。
- 2005-2012年男性年龄调整年率变化为-3.9%,女性为-4.5%,几乎所有年龄组均下降。
临床怎么用
- 提示临床对65岁以上成人,尤其是男性,应警惕侵袭性念珠菌病风险。
- 高 mortality 和长住院时间提示需关注该病的早期识别与防控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Invasive candidiasis is a major nosocomial fungal disease in the United States associated with high rates of illness and death. We analyzed inpatient hospitalization records from the Healthcare Cost and Utilization Project to estimate incidence of invasive candidiasis-associated hospitalizations in the United States. We extracted data for 33 states for 2002-2012 by using codes from the International Classification of Diseases, 9th Revision, Clinical Modification, for invasive candidiasis; we excluded neonatal cases. The overall age-adjusted average annual rate was 5.3 hospitalizations/100,000 population. Highest risk was for adults >65 years of age, particularly men. Median length of hospitalization was 21 days; 22% of patients died during hospitalization. Median unadjusted associated cost for inpatient care was $46,684. Age-adjusted annual rates decreased during 2005-2012 for men (annual change -3.9%) and women (annual change -4.5%) and across nearly all age groups. We report a high mortality rate and decreasing incidence of hospitalizations for this disease.
引用
- Strollo S, Lionakis MS, Adjemian J, et al. Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002-20121. Emerg Infect Dis. 2016. PMID: 27983497. doi:10.3201/eid2301.161198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。